You're receiving this email because you're subscribed to Ring the Bell from Benzinga. To manage your subscription, click the link at the bottom of this email.

Happy Tuesday! My neighborhood is starting to get a little spooky with Halloween right around the corner. But I recently did something that’s scarier than ghosts, ghouls or skeletons: I bought Chinese stocks. And so far, it’s been more of a treat than a trick. Also, are weight-loss drug makers in trouble?

—Aaron Bry

Plus, if you still haven’t invested in Bitcoin but would like to, today’s partner can help you get started.

MARKET SNAPSHOT

Yesterday: Was a good day for the bulls. All major indices closed in the green, with Tesla leading the way for tech stocks, finishing the session up nearly 5%.

On Our Radar: More earnings are set to roll in with companies like KB Homes, Micron, Autozone, and more reporting.

TOP STORY

Chinese Stocks Rally To 4-Month Highs As Central Bank Slashes Interest Rates

Basically: Chinese stocks surged to their highest levels in four months on Monday, following the People’s Bank of China’s (PBoC) slashing a key interest rate.

So: The surprise move reignites hopes for additional stimulus in the world’s second-largest economy. Here are the stocks that could benefit the most.

PRESENTED BY SEASONAL TOKENS

The Winter Halving Is Near: Here's How Seasonal Tokens Can Help You Grab Some BTC

The four Seasonal Tokens, including Spring, Summer, Autumn and Winter, are produced by proof-of-work mining, similar to Bitcoin. But Seasonal Tokens prices are unique in that they can be controlled by the mining supply. As investors swap one of the Seasonal Tokens for another, they help to drive the price higher and reward miners. Holders of Seasonal Tokens can also swap them for Wrapped Bitcoin, which in turn can be exchanged on a 1:1 basis for actual Bitcoin. The Seasonal Tokens project is preparing for its Winter halving event in September, offering investors and miners an opportunity to participate in the event.

FIVE ZINGERS

Like A Roll Of Charmin: Goldman Sachs is still calling for a soft landing following the Fed’s .5% rate cut. Here’s what an ultra-soft landing would mean for your portfolio.

Let It $SNOW: Snowflake shares got hammered overnight after the company announced a new offering. Here are other stocks trading lower to start the day.

Where The Strength Is: While the U.S. cuts interest rates, fund managers are looking for opportunities in these sectors for gains.

Trend Is Your Friend: Oracle shares have been on fire, up nearly 20% in the last month. But, will it continue to run?

Your Chance At $30k Risk-Free: Benzinga's World Championship of Trading is about to take off, and all you have to do is sign up and paper trade for your chance at the prizes.

ONE FOR THE ROAD

'Miracle' Weight Loss Drug Ozempic To Enter US Price Negotiations Within A Year, Novo Nordisk CEO Says Ahead Of Senate Hearing

Basically: Novo Nordisk's CEO Lars Fruergaard Jorgensen, has revealed that their diabetes medication and often hailed as a “miracle” weight loss drug, Ozempic will soon be eligible for U.S. government price negotiations, potentially within the next year.

What Happened: Jorgensen is scheduled to testify before a Senate committee on Tuesday to discuss U.S. pricing for Ozempic and the weight loss drug Wegovy. The comments align with Wall Street analysts’ expectations that Ozempic will be on the 2027 price negotiation list, which will be announced in February 2025, Reuters reported. Here’s what the news means for Eli Lilly and Novo Nordisk shares.

PRESENTED BY BENZINGA

New Recommendation: Add These Top Growth Stocks to Your Portfolio Today

While most people hope to find "the next Apple," there's one investor who's been making massive profits with little-known, undervalued stocks — for the last 30 years. Just recently he published his entire portfolio of the best growth stocks available currently… click here to learn how to gain access to it now.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators, and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis, and news. Subscribe here.